No items found.
The GenoRx Program uses Pharmacogenomics, or PGx testing to study an individual's response to drugs. We’ve learned through research that genes play a role in how the body responds to medications. PGx testing can lead to more informed prescribing, increased medication adherence, and reduce the trial and error for treatments prescribed to manage many common conditions like cardiovascular disease, depression and anxiety, cancer, infectious disease, pain, and many others.
1. Mental health prescribing,
2. Clopidogrel and cardiovascular events, and
3. Polypharmacy to optimize prescribing for patients over 65 who are on multiplechronic medications.
Stay up to date on our research by following some of our primary researchers: